STOCK TITAN
  1. Home
  2. Sec-filings
  3. GCTK
  4. [EFFECT] Glucotrack, Inc. SEC Filing

[EFFECT] Glucotrack, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 27, 2026 4:05 P.M.
Form: S-3
CIK: 0001506983
Company Name: Glucotrack, Inc.
File Number: 333-292695

Source: View Original Filing on SEC EDGAR

Glucotrack

NASDAQ:GCTK

View GCTK Stock Overview →

GCTK Rankings

#7055 Ranked by Market Cap
N/A Ranked by Dividends

GCTK Latest News

Mar 30, 2026
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Mar 27, 2026
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
Mar 10, 2026
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
Jan 29, 2026
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
Dec 30, 2025
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

GCTK Latest SEC Filings

Mar 30, 2026
[10-K] Glucotrack, Inc. Files Annual Report
Mar 30, 2026
[8-K] Glucotrack, Inc. Reports Material Event
Mar 27, 2026
[8-K] Glucotrack, Inc. Reports Material Event
Mar 13, 2026
[8-K] Glucotrack, Inc. Reports Material Event
Feb 17, 2026
[SCHEDULE 13G] Glucotrack, Inc. Passive Investment Disclosure (>5%)

GCTK Stock Data

1.00M
952.41k
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
RUTHERFORD